Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
Clinical trial NCT00622193 · COMPLETED
Trial details
- NCT number
- NCT00622193
- Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-12-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.